Evidence map›Paper›PMID 41477505›Full record

ArticleHeliyon2025

Green-based anti-biofilm nanoformulations against bacterial contaminations in nosocomial environments.

Giovanni Lo Bello, Elena Dellacasa, Giacomo Damonte, Debora Caviglia, Anna Maria Schito, Roberto Raiteri, Orietta Monticelli, Marina Sartini, Maria Luisa Cristina, Laura Pastorino

Abstract read
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giovanni Lo BelloDepartment of Informatics, Bioengineering, Robotics, and System Engineering, University of Genova, Via Opera Pia 13, 16145, Genova, Italy.
Elena DellacasaDepartment of Informatics, Bioengineering, Robotics, and System Engineering, University of Genova, Via Opera Pia 13, 16145, Genova, Italy.
Giacomo DamonteDepartment of Chemistry and Industrial Chemistry, University of Genova, Via Dodecaneso 31, 16146, Genova, Italy.
Debora CavigliaDepartment of Integrated Surgical and Diagnostical Sciences, University of Genoa, Viale Benedetto XV 6, 16132, Genoa, Italy.
Anna Maria SchitoDepartment of Integrated Surgical and Diagnostical Sciences, University of Genoa, Viale Benedetto XV 6, 16132, Genoa, Italy.
Roberto RaiteriDepartment of Informatics, Bioengineering, Robotics, and System Engineering, University of Genova, Via Opera Pia 13, 16145, Genova, Italy.
Orietta MonticelliDepartment of Chemistry and Industrial Chemistry, University of Genova, Via Dodecaneso 31, 16146, Genova, Italy.
Marina SartiniDepartment of Health Science, University of Genova, Via Pastore 1, 16132, Genova, Italy.
Maria Luisa CristinaDepartment of Health Science, University of Genova, Via Pastore 1, 16132, Genova, Italy.
Laura PastorinoDepartment of Informatics, Bioengineering, Robotics, and System Engineering, University of Genova, Via Opera Pia 13, 16145, Genova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α-amylase enzyme molecules were conjugated to biocompatible and biodegradable

Indexed as

Antibiofilm nanoplatformNosocomial infectionsPCL nanoparticlesStaphylococcus aureusα-amylase

Identifiers

PMID41477505
PMCPMC11908580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.